How have GENF shares performed in 2024?

Genflow Biosciences' stock was trading at GBX 1.43 on January 1st, 2024. Since then, GENF stock has increased by 31.9% and is now trading at GBX 1.88. View the best growth stocks for 2024 here .

How do I buy shares of Genflow Biosciences?

Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:GENF

Genflow Biosciences (GENF) Share Price, News & Analysis

→ His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad)

Free GENF Stock Alerts

GBX 1.85

+0.05 (+2.78%)

(As of 07:42 AM ET)

Compare

Today's Range: 1.85
▼
2
50-Day Range: 1.35
▼
1.80
52-Week Range: 1.32
▼
4.25

Volume: 992,891 shs
Average Volume: 1.18 million shs
Market Capitalization: £6.47 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors

Get Genflow Biosciences alerts:

Ad Investing Daily

His win rate puts Warren Buffett to shame…

Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.

Click here now for the full story.

About Genflow Biosciences

Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

GENF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GENF Stock News Headlines

April 6, 2023 | investing.com

Genflow Biosciences PLC (GENF)

April 6, 2023 | finance.yahoo.com

Companies Like Genflow Biosciences (LON:GENF) Can Afford To Invest In Growth

See More Headlines

Receive GENF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:GENF
CUSIP: N/A
CIK: N/A
Web: genflowbio.com
Phone: 44 32 4774 95881
Fax: N/A
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-1,180,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -51.61%
Return on Assets: -30.00%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 9.83
Quick Ratio: 20.20

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: GBX 0.62 per share
Price / Cash Flow: 3.00
Book Value: GBX 1 per share
Price / Book: 1.85

Miscellaneous

Outstanding Shares: 349,710,000
Free Float: N/A
Market Cap: £6.47 million
Optionable: Not Optionable
Beta: 2.47

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Dr. Eric Jean Leire M.D. (Age 66)
MBA, Founder, CEO & Executive Director
Comp: $235.43k
Dr. Cedric Szpirer
Head of CMC

Key Competitors

View All Competitors

GENF Stock Analysis - Frequently Asked Questions

How have GENF shares performed in 2024?: Genflow Biosciences' stock was trading at GBX 1.43 on January 1st, 2024. Since then, GENF stock has increased by 31.9% and is now trading at GBX 1.88.
View the best growth stocks for 2024 here.
How do I buy shares of Genflow Biosciences?: Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:GENF) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial